1 / 8

Data Supports Cost Effectiveness of Continuous External Tissue Expansion

Data Supports Cost Effectiveness of Continuous External Tissue Expansion. Mayo Clinic Data. 24 Patient Cohort (27 wounds) Mean wound area was 74.7 cm 2 (range 5.2 to 230.5 cm 2 ) Mean duration of CETE was 7.2 days (range 2 to 20 days).

amal
Download Presentation

Data Supports Cost Effectiveness of Continuous External Tissue Expansion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Data Supports Cost Effectiveness of Continuous External Tissue Expansion

  2. Mayo Clinic Data 24 Patient Cohort (27 wounds) Mean wound area was 74.7 cm2 (range 5.2 to 230.5 cm2) Mean duration of CETE was 7.2 days (range 2 to 20 days). 77.7% of wounds were closed with Delayed Primary Closure The average decrease in wound was 85%. The six wounds that were not able to be closed primarily showed an average decrease in wound area of 50.5%. * Presented at the ASPS Senior Residents Forum 2011 and submitted for publication by HumbertoPalladino M.D. et.al.

  3. Mayo Clinic Patient Data Effect of continuous external tissue expansion (CETE) on wound area.

  4. Walter Reed / National Naval Data 15 Patient Cohort Overall time to wound coverage ranged from 1-17 days (mean of 6.5 days) Wounds ranged from 20.25 cm² to 1031.25 cm² with a mean wound size was 239.75 cm2 Decrease in wound size area ranged from 36% - 93% (mean of 67.89%) Of the 15 patients included in the series 13 (86.6%) were able to undergo delayed primary closure * Abstract accepted for presentation at the NESPS Annual meeting 2011 by Gabriel Santiago M.D. et.al.

  5. Cost Effectiveness Although specific comparative data to show cost effectiveness was not part of these two studies here are several points to consider: • The majority of wounds in these two studies were closed with delayed primary closure (DPC) in lieu of more complex and time consuming surgical procedures • Wounds that were closed with DPC were closed in an average of 7 days

  6. Cost Effectiveness • The wounds not closed with DPC were reduced in size by greater than 50%. • Faster time to closure frequently equates to reduced length of stay in the hospital • Reduced “surgical burden” frequently equates to less OR time per case

  7. Cost Effectiveness • Faster wound closure or smaller wounds require less time for dressing changes and need for prolonged NPWT therapy • Faster wound closure may result in fewer costly “never events” • Improved clinical outcomes results in improved patient satisfaction

  8. Summary • There is a clear path to cost effectiveness with the appropriate use of continuous external tissue expansion • The expense of utilizing continuous external tissue expansion is minimal compared to the possible savings • Data is currently being collected by credible investigators to quantify the economic impact of this novel technology on cost of care

More Related